The American Society for Biochemistry and Molecular Biology have announced that Alex Toker, associate director for the Cancer Research Institute at Beth Israel Deaconess Medical Center and professor of pathology at Harvard Medical School, will be the next editor-in-chief of the Journal of Biological Chemistry, one of the society’s three open-access, peer-reviewed journals. Toker’s five-year term will begin October 1.
Toker has a long relationship with the journal. He has been a deputy editor since 2020, an associate editor since 2013 and before that was an editorial board member. He also has served as chair of the editorial advisory board for the member magazine, ASBMB Today, the society’s news magazine.
He is an expert in the signaling mechanisms that govern cancer progression. His lab specifically focuses on the PI3K signaling pathway in breast and other cancers and the mechanisms by which the protein kinase AKT promotes tumor cell survival and growth and the metabolic reprogramming of cancer cells.
Toker succeeds as editor-in-chief Lila Gierasch, a distinguished professor and former department head at the University of Massachusetts Amherst, whose five-year term ended June 30. Toker will technically take the reins from the journal’s interim editor, F. Peter Guengerich, a researcher at Vanderbilt University and longtime journal leader.
Click here to read the original press release.
